+51.6%
CME vs SPMO
+159.2%
-107.6%
-31.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SPMO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.8% | -0.1% | -0.7% | -0.8% |
| 7D | -0.6% | +2.7% | -3.3% | -0.3% |
| 30D | +4.7% | +1.1% | +3.6% | +4.8% |
| 3M | +7.8% | +2.0% | +5.8% | +8.3% |
| 6M | -11.0% | +26.5% | -37.5% | -9.4% |
| YTD | +4.0% | +26.5% | -22.5% | +5.9% |
| 1Y | +9.1% | +27.9% | -18.8% | +11.1% |
| All | +51.6% | +159.2% | -107.6% | +43.1% |
Cumulative growth
Daily Returns
Daily percentage return beside SPMO.
Daily Out/Under-Performance
Portfolio return minus SPMO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPMO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SPMO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling